Safety and Efficacy of Serplulimab Combined with Neoadjuvant Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer: A Retrospective Study

Meng Tian,1,2,* Minghui Zhao,2,* Linhong Jiang,2,* Jia Liu,2,* Gefenqiang Shen,2 Zhaoyue Zhang,2,3 Caiqiang Zhu,1 Sheng Zhang,2 Xinchen Sun,2 Yujing Shi,1 Xiaoke Di1,2 1Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, People’s Repub...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tian M, Zhao M, Jiang L, Liu J, Shen G, Zhang Z, Zhu C, Zhang S, Sun X, Shi Y, Di X
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Dove Medical Press 2025-11-01
Saila:	Cancer Management and Research
Gaiak:	locally advanced rectal cancer neoadjuvant chemoradiotherapy Serplulimab neoadjuvant immunotherapy pathological complete response
Sarrera elektronikoa:	https://www.dovepress.com/safety-and-efficacy-of-serplulimab-combined-with-neoadjuvant-chemoradi-peer-reviewed-fulltext-article-CMAR
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!